Neurodegenerative disease biomarkers based on high quality wireless EEG.

Projektinformationen

NEUMARQ

ID Finanzhilfevereinbarung: 662975

DOI 10.3030/662975

Abgeschlossenes Projekt

EK-Unterschriftsdatum 18 Dezember 2014

Startdatum 1 Januar 2015

Enddatum 30 Juni 2015

Finanziert unter

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Gesamtkosten € 71 429,00

EU-Beitrag € 50 000,00

Koordiniert durch

STARLAB BARCELONA SL
Spain

Ziel

The need: Today, although over 6M people suffer from Parkinson's and related diseases worldwide we have no objective early diagnostic test. By the time patients present the symptoms that lead to diagnosis the disease is already very advanced and the options for treatment extremely limited. This has an enormous impact on cost of care and an even greater impact on patient and carer quality of life. An early diagnostic test will revolutionise treatment in terms of slowing disease evolution and improved outcomes, with fewer years in the advanced phases of the disease requiring expensive full-time care.
Our goal: We aim to commercialise non-invasive, very low-cost preclinical electroencephalograph (EEG) biomarkers for synucleinopathies (Parkinson Disease - PD and Lewy Body Dementia - LBD), which will have real impact on both quality of life and cost of care.

Wissenschaftliches Gebiet

• social sciences › economics and business › business and management › business models
• medical and health sciences › basic medicine › neurology › dementia
• medical and health sciences › basic medicine › neurology › parkinson

Programm/Programme

• H2020-EU.3.1. - SOCIETAL CHALLENGES - Health, demographic change and well-being Main Programme
• H2020-EU.3.1.3. - Treating and managing disease

Thema/Themen

• PHC-12-2014-1 - Clinical research for the validation of biomarkers and/or diagnostic medical devices

Aufforderung zur Vorschlagseinreichung

H2020-SMEInst-2014-2015

Andere Projekte für diesen Aufruf anzeigen

Unterauftrag

H2020-SMEINST-1-2014

Finanzierungsplan

SME-1 - SME instrument phase 1

Koordinator

STARLAB BARCELONA SL

• Netto-EU-Beitrag: € 50 000,00
• Adresse: AVENIDA TIBIDABO 47 BIS ; 08035 Barcelona ; Spanien
• KMU Die Organisation definierte sich zum Zeitpunkt der Unterzeichnung der Finanzhilfevereinbarung selbst als KMU (Kleine und mittlere Unternehmen). Ja:
  Region
  Este › Cataluña › Barcelona
• Region: Este › Cataluña › Barcelona
• Aktivitätstyp: Private for-profit entities (excluding Higher or Secondary Education Establishments)
• Gesamtkosten: € 71 429,00